| Bioactivity | PDZ1 Domain inhibitor peptide TFA, a cyclic peptide, incorporates a β-Ala lactam side chain linker and targets the PDZ1 domains of the postsynaptic density protein 95 (PSD-95). PDZ1 Domain inhibitor peptide TFA disrupts the GluR6/PSD-95 interaction and is very efficient in competing against the C terminus of GluR6 for the PDZ1 domain[1]. |
| Name | PDZ1 Domain inhibitor peptide TFA |
| Shortening | YKKTEAV (Lactam bridge:Lys3-Glu5) |
| Formula | C40H62F3N9O13 |
| Molar Mass | 933.97 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Andrea Piserchio, et al. Targeting specific PDZ domains of PSD-95; structural basis for enhanced affinity and enzymatic stability of a cyclic peptide. Chem Biol. 2004 Apr;11(4):469-73. |
PDZ1 Domain inhibitor peptide TFA
CAS: F: C40H62F3N9O13 W: 933.97
PDZ1 Domain inhibitor peptide TFA, a cyclic peptide, incorporates a β-Ala lactam side chain linker and targets the PDZ1
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.